NITRENDIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE TREATMENT OF HYPERTENSION

被引：121

作者：

GOA, KL

SORKIN, EM

机构：

来源：

关键词：

D O I：

10.2165/00003495-198733020-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：123 / 155

页数：33

共 162 条

[71] 1,4-DIHYDROPYRIDINE CA-2+ CHANNEL ANTAGONISTS AND ACTIVATORS - A COMPARISON OF BINDING CHARACTERISTICS WITH PHARMACOLOGY
JANIS, RA
TRIGGLE, DJ
[J]. DRUG DEVELOPMENT RESEARCH, 1984, 4 (03) : 257 - 274
[72] JANIS RA, 1984, J PHARMACOL EXP THER, V231, P8
[73] JOHNS EJ, 1986, JUN INT WORKSH REN E
[74] HEMODYNAMIC AND METABOLIC EFFECTS OF THE CALCIUM-CHANNEL BLOCKING-AGENT NITRENDIPINE
JOHNSON, BF
ROMERO, L
MARWAHA, R
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (04) : 389 - 394
[75] JONES C A, 1984, American Review of Respiratory Disease, V129, pA233
[76] KANN J, 1984, J CARDIOVASC PHARM, V6, pS968
[77] CELLULAR ACTIONS AND PHARMACOLOGY OF THE CALCIUM-CHANNEL BLOCKING-DRUGS
KATZ, AM
HAGER, WD
MESSINEO, FC
PAPPANO, AJ
[J]. AMERICAN JOURNAL OF MEDICINE, 1984, 77 (2B) : 2 - 10
[78] AGE, RACE, BLOOD-PRESSURE AND RENIN - PREDICTORS FOR ANTIHYPERTENSIVE TREATMENT WITH CALCIUM-ANTAGONISTS
KIOWSKI, W
BUHLER, FR
FADAYOMI, MO
ERNE, P
MULLER, FB
HULTHEN, UL
BOLLI, P
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (16) : H81 - H85
[79] KIRCH W, 1984, J CARDIOVASC PHARM, V6, pS982
[80] KIRCH W, 1986, J CLIN PHARMACOL, V26, P553